CADD522 is a RUNX2-DNA binding inhibitor (downregulates RUNX2-mediated transcription of downstream target genes), with an IC50 of 10 nM. CADD522 inhibits primary tumor growth and experimental metastasis of tumor cells in the lungs of immune-compromi 1 * 100 mg
Catalog # MDEXHY-107999
Supplier: MEDCHEMEXPRESS
Frequently Bought Together